Characteristics of primary care physicians and their practices associated with mammography rates for older women.

PubWeight™: 0.95‹?› | Rank: Top 15%

🔗 View Article (PMID 14584062)

Published in Cancer on November 01, 2003

Authors

R Van Harrison1, Nancy K Janz, Robert A Wolfe, Philip J Tedeschi, Jeoffrey K Stross, Xuelin Huang, Laurence F McMahon

Author Affiliations

1: Department of Medical Education, University of Michigan, Ann Arbor, Michigan 48109, USA. rvh@umich.edu

Articles by these authors

Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology (2003) 10.11

Chronic renal failure after transplantation of a nonrenal organ. N Engl J Med (2003) 8.47

Results of a randomized study of 3 schedules of low-dose decitabine in higher-risk myelodysplastic syndrome and chronic myelomonocytic leukemia. Blood (2006) 8.38

The survival benefit of liver transplantation. Am J Transplant (2005) 5.08

Spectrum of cancer risk among US solid organ transplant recipients. JAMA (2011) 4.99

A comprehensive risk quantification score for deceased donor kidneys: the kidney donor risk index. Transplantation (2009) 4.45

Deceased-donor characteristics and the survival benefit of kidney transplantation. JAMA (2005) 4.16

Effects of work hour reduction on residents' lives: a systematic review. JAMA (2005) 3.97

Effect of changing the priority for HLA matching on the rates and outcomes of kidney transplantation in minority groups. N Engl J Med (2004) 3.96

Health-related quality of life as a predictor of mortality and hospitalization: the Dialysis Outcomes and Practice Patterns Study (DOPPS). Kidney Int (2003) 3.90

Adherence to colorectal cancer screening: a randomized clinical trial of competing strategies. Arch Intern Med (2012) 3.79

Vascular access use in Europe and the United States: results from the DOPPS. Kidney Int (2002) 3.79

Renal transplantation in elderly patients older than 70 years of age: results from the Scientific Registry of Transplant Recipients. Transplantation (2007) 3.69

Patient involvement in surgery treatment decisions for breast cancer. J Clin Oncol (2005) 3.65

Association of comorbid conditions and mortality in hemodialysis patients in Europe, Japan, and the United States: the Dialysis Outcomes and Practice Patterns Study (DOPPS). J Am Soc Nephrol (2003) 3.53

Donor characteristics associated with reduced graft survival: an approach to expanding the pool of kidney donors. Transplantation (2002) 3.42

Facility hemodialysis vascular access use and mortality in countries participating in DOPPS: an instrumental variable analysis. Am J Kidney Dis (2009) 2.93

Shared frailty models for recurrent events and a terminal event. Biometrics (2004) 2.86

The Dialysis Outcomes and Practice Patterns Study (DOPPS): design, data elements, and methodology. Am J Kidney Dis (2004) 2.82

Can a disease self-management program reduce health care costs? The case of older women with heart disease. Med Care (2003) 2.78

Satisfaction with surgery outcomes and the decision process in a population-based sample of women with breast cancer. Health Serv Res (2005) 2.75

Longitudinal assessment of mortality risk among candidates for liver transplantation. Liver Transpl (2003) 2.68

Effect of nonpayment for hospital-acquired, catheter-associated urinary tract infection: a statewide analysis. Ann Intern Med (2012) 2.44

A randomized study of clofarabine versus clofarabine plus low-dose cytarabine as front-line therapy for patients aged 60 years and older with acute myeloid leukemia and high-risk myelodysplastic syndrome. Blood (2008) 2.31

DNA methylation predicts survival and response to therapy in patients with myelodysplastic syndromes. J Clin Oncol (2009) 2.23

Prediction of Barrett's esophagus among men. Am J Gastroenterol (2013) 2.22

Visual field progression in the Collaborative Initial Glaucoma Treatment Study the impact of treatment and other baseline factors. Ophthalmology (2008) 2.20

The influence of race, ethnicity, and individual socioeconomic factors on breast cancer stage at diagnosis. Am J Public Health (2006) 2.20

Decision involvement and receipt of mastectomy among racially and ethnically diverse breast cancer patients. J Natl Cancer Inst (2009) 2.18

Latina patient perspectives about informed treatment decision making for breast cancer. Patient Educ Couns (2008) 2.17

Correlates of between-surgeon variation in breast cancer treatments. Med Care (2006) 2.08

Systematic review: effects of resident work hours on patient safety. Ann Intern Med (2004) 2.07

Quality of life in chronic kidney disease (CKD): a cross-sectional analysis in the Renal Research Institute-CKD study. Am J Kidney Dis (2005) 2.05

Metastatic melanoma to lymph nodes in patients with unknown primary sites. Cancer (2006) 1.93

Immunosuppression and the risk of post-transplant malignancy among cadaveric first kidney transplant recipients. Am J Transplant (2004) 1.90

Survival advantage with decitabine versus intensive chemotherapy in patients with higher risk myelodysplastic syndrome: comparison with historical experience. Cancer (2007) 1.88

Association between vascular access failure and the use of specific drugs: the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis (2002) 1.87

Valganciclovir prevents cytomegalovirus reactivation in patients receiving alemtuzumab-based therapy. Blood (2007) 1.87

An informed decision? Breast cancer patients and their knowledge about treatment. Patient Educ Couns (2006) 1.87

Cancers of the kidney and urinary tract in patients on dialysis for end-stage renal disease: analysis of data from the United States, Europe, and Australia and New Zealand. J Am Soc Nephrol (2003) 1.84

Patterns and correlates of patient referral to surgeons for treatment of breast cancer. J Clin Oncol (2007) 1.84

Mortality and hospitalization in haemodialysis patients in five European countries: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant (2004) 1.83

CCL3 (MIP-1α) plasma levels and the risk for disease progression in chronic lymphocytic leukemia. Blood (2010) 1.82

Cytogenetic and molecular responses and outcome in chronic myelogenous leukemia: need for new response definitions? Cancer (2008) 1.80

Correlates of breast reconstruction: results from a population-based study. Cancer (2005) 1.79

Clofarabine combinations as acute myeloid leukemia salvage therapy. Cancer (2008) 1.77

The minimum important differences for the urinary scales of the Pelvic Floor Distress Inventory and Pelvic Floor Impact Questionnaire. Am J Obstet Gynecol (2009) 1.73

Dialysis dose and body mass index are strongly associated with survival in hemodialysis patients. J Am Soc Nephrol (2002) 1.73

Influence of graft type on outcomes after pediatric liver transplantation. Am J Transplant (2004) 1.72

Health-related quality of life and associated outcomes among hemodialysis patients of different ethnicities in the United States: the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis (2003) 1.72

Improved survival in chronic myeloid leukemia since the introduction of imatinib therapy: a single-institution historical experience. Blood (2012) 1.69

Effect of body mass index on the survival benefit of liver transplantation. Liver Transpl (2007) 1.69

A sequential stratification method for estimating the effect of a time-dependent experimental treatment in observational studies. Biometrics (2006) 1.63

Factors associated with receipt of breast cancer adjuvant chemotherapy in a diverse population-based sample. J Clin Oncol (2012) 1.63

Hospital report cards for hospital-acquired pressure ulcers: how good are the grades? Ann Intern Med (2013) 1.57

Hospital-acquired catheter-associated urinary tract infection: documentation and coding issues may reduce financial impact of Medicare's new payment policy. Infect Control Hosp Epidemiol (2010) 1.56

Racial and ethnic disparities in the use of postmastectomy breast reconstruction: results from a population- based study. J Clin Oncol (2009) 1.56

Patterns and correlates of local therapy for women with ductal carcinoma-in-situ. J Clin Oncol (2005) 1.53

Using knowledge of multiple levels of variation in care to target performance incentives to providers. Med Care (2008) 1.53

Hepatitis C is a risk factor for death after liver retransplantation. Liver Transpl (2005) 1.48

Breast cancer treatment experiences of Latinas in Los Angeles County. Am J Public Health (2005) 1.48

The use of Gaussian quadrature for estimation in frailty proportional hazards models. Stat Med (2008) 1.47

Dialysis dose scaled to body surface area and size-adjusted, sex-specific patient mortality. Clin J Am Soc Nephrol (2012) 1.47

Factors associated with patient involvement in surgical treatment decision making for breast cancer. Patient Educ Couns (2006) 1.46

Overexpression of CXCR4 predicts adverse overall and event-free survival in patients with unmutated FLT3 acute myeloid leukemia with normal karyotype. Cancer (2007) 1.46

Facility-level interpatient hemoglobin variability in hemodialysis centers participating in the Dialysis Outcomes and Practice Patterns Study (DOPPS): Associations with mortality, patient characteristics, and facility practices. Am J Kidney Dis (2011) 1.45

Reliability of health-related quality-of-life measures 1 year after surgical procedures for pelvic floor disorders. Am J Obstet Gynecol (2005) 1.44

The hospitalist movement--time to move on. N Engl J Med (2007) 1.44

Effect of complete remission and responses less than complete remission on survival in acute myeloid leukemia: a combined Eastern Cooperative Oncology Group, Southwest Oncology Group, and M. D. Anderson Cancer Center Study. J Clin Oncol (2010) 1.43

Detection of MRD may predict the outcome of patients with Philadelphia chromosome-positive ALL treated with tyrosine kinase inhibitors plus chemotherapy. Blood (2013) 1.42

Cohort analysis of patients with localized, high-risk, extremity soft tissue sarcoma treated at two cancer centers: chemotherapy-associated outcomes. J Clin Oncol (2004) 1.41

The survival advantage for haemodialysis patients taking vitamin D is questioned: findings from the Dialysis Outcomes and Practice Patterns Study. Nephrol Dial Transplant (2008) 1.39

Hemodialysis vascular access preferences and outcomes in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Kidney Int (2002) 1.34

Analysis of longitudinal data in the presence of informative observational times and a dependent terminal event, with application to medical cost data. Biometrics (2007) 1.32

Clofarabine plus low-dose cytarabine followed by clofarabine plus low-dose cytarabine alternating with decitabine in acute myeloid leukemia frontline therapy for older patients. Cancer (2012) 1.31

The role of choice in health education intervention trials: a review and case study. Soc Sci Med (2003) 1.30

Use of critical pathways to improve efficiency: a cautionary tale. Am J Manag Care (2003) 1.27

A theory-based reproductive health and diabetes instrument. Am J Health Behav (2006) 1.26

Survivin is highly expressed in CD34(+)38(-) leukemic stem/progenitor cells and predicts poor clinical outcomes in AML. Blood (2012) 1.25

Taking CHARGE: A self-management program for women following breast cancer treatment. Psychooncology (2005) 1.23

Validation of tissue microarray technology in ovarian carcinoma. Mod Pathol (2004) 1.22

Adjuvant endocrine therapy initiation and persistence in a diverse sample of patients with breast cancer. Breast Cancer Res Treat (2013) 1.21

DOPPS estimates of patient life years attributable to modifiable hemodialysis practices in the United States. Blood Purif (2004) 1.21

Further validation of the short form versions of the Pelvic Floor Distress Inventory (PFDI) and Pelvic Floor Impact Questionnaire (PFIQ). Neurourol Urodyn (2011) 1.21

The collaborative initial glaucoma treatment study: baseline visual field and test-retest variability. Invest Ophthalmol Vis Sci (2003) 1.20

Kidney transplantation and wait-listing rates from the international Dialysis Outcomes and Practice Patterns Study (DOPPS). Kidney Int (2005) 1.20

The impact of sociodemographic, treatment, and work support on missed work after breast cancer diagnosis. Breast Cancer Res Treat (2009) 1.19

Racial/ethnic disparities in knowledge about risks and benefits of breast cancer treatment: does it matter where you go? Health Serv Res (2008) 1.19

p53 activation of mesenchymal stromal cells partially abrogates microenvironment-mediated resistance to FLT3 inhibition in AML through HIF-1α-mediated down-regulation of CXCL12. Blood (2011) 1.16

Impact of years of dialysis therapy on mortality risk and the characteristics of longer term dialysis survivors. Am J Kidney Dis (2002) 1.15

Blood pressure levels and mortality risk among hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study. Kidney Int (2012) 1.15

The report of a national conference on the wait list for kidney transplantation. Am J Transplant (2003) 1.14

Surgeon perspectives about local therapy for breast carcinoma. Cancer (2005) 1.13

Eradication of minimal residual disease in hairy cell leukemia. Blood (2006) 1.13

Depression and mood indicators in newly diagnosed glaucoma patients. Am J Ophthalmol (2007) 1.12

Where should hospitalists sit within the academic medical center? J Gen Intern Med (2008) 1.10

Associations of diabetes mellitus, insulin, leptin, and ghrelin with gastroesophageal reflux and Barrett's esophagus. Gastroenterology (2013) 1.09

Cataract extraction in the collaborative initial glaucoma treatment study: incidence, risk factors, and the effect of cataract progression and extraction on clinical and quality-of-life outcomes. Arch Ophthalmol (2006) 1.08

Use of urinary collection devices in skilled nursing facilities in five states. J Am Geriatr Soc (2008) 1.08